← All organizations

Hangzhou Highlightll Pharmaceutical Co., Ltd

For profit

Also known as: Hangzhou Highlightll Pharmaceutical Co., Ltd | Highlightll Pharmaceutical (USA) LLC | TLL Pharmaceutical, LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Apr 25, 2025

Timeline

2010s

Jan 1, 2015
Hangzhou Highlightll Pharmaceutical Co., Ltd— Founded

Drugs by trial phase (4 distinct, 11 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

tll018

Phase 1 (1 own, 0 via acquisition)

hl-400

Recent trials (12)

NCT06997484Lead sponsorPhase 1Apr 25, 2025
NCT06887127Lead sponsorPhase 3Mar 10, 2025
NCT06396026Lead sponsorPhase 3May 30, 2024
NCT06020144Lead sponsorPhase 3Nov 15, 2023
NCT05945810Lead sponsorPhase 1Jul 12, 2023
NCT05772520Lead sponsorPhase 2Jan 19, 2023
NCT05342428Lead sponsorPhase 1Jun 10, 2022
NCT05373355Lead sponsorPhase 1May 10, 2022
NCT05133297Lead sponsorPhase 2Dec 31, 2021
NCT05121402Lead sponsorPhase 2Dec 30, 2021
NCT05121402CollaboratorPhase 2Dec 30, 2021
NCT04243083Lead sponsorPhase 1Jan 26, 2020

Details

Founded: Palm Beach Gardens, FL, US Jan 1, 2015
Last known activity: Apr 25, 2025

Notes

--- Pre-folding founded info: 2017-06-01 Hangzhou None China https://profiles.biocentury.com/companies/hangzhou_highlightll_pharmaceutical_co_ltd ---